Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. L. Paggiaro (Pisa, Italy). What is COPD? What is asthma?. ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Comorbidities – should we and how should we treat them in asthma and COPD? Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 A typical COPD exacerbation? Source: Breathe 2008; 4: 346-354 Year: 2008 Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 COPD: An outcome of childhood asthma? Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010 PCD or asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 295s Year: 2001 Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004 What is difficult asthma? Source: Annual Congress 2003 - Difficult paediatric asthma Year: 2003 Breathlessness, could it be asthma? Source: Virtual Congress 2020 – Part I: From symptoms to diagnosis in primary care Year: 2020 What do patients want? Preferences for two asthma regimens in mild/moderate asthma Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Ventilation heterogeneity reversibility: asthma, COPD or ACOS? Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Are we really transforming asthma and COPD management with biologics? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 Is it time to give up on “self-management” of COPD exacerbations? Source: Eur Respir J, 55 (1) 1902102; 10.1183/13993003.02102-2019 Year: 2020